Despite Modest Decline, NFL Concussion Rate Remains Work in Progress
New data shows players suffered 244 concussions this season —down from a year ago but still way above number from 2014 (Source: WSJ.com: Health)
Source: WSJ.com: Health - January 26, 2017 Category: Pharmaceuticals Tags: FREE Source Type: news

J & J's $30 Billion Biotech Deal Carves Out Drug-Discovery Unit
Johnson& Johnson has agreed to acquire Actelion, Europe ’s biggest biotech company, for $30 billion, bolstering the U.S. pharmaceutical giant’s portfolio of rare-disease treatments as its top-selling drug faces new competition. (Source: WSJ.com: Health)
Source: WSJ.com: Health - January 26, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news

Judge Blocks Rule That Would Limit Premium Assistance for Dialysis Patients
A judge issued an order delaying a rule indefinitely that was expected to limit dialysis providers ’ ability to help patients pay for individual insurance plans. (Source: WSJ.com: Health)
Source: WSJ.com: Health - January 26, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news

Massachusetts Governor Pitches Health-Insurance Penalty for Employers
The first state in the nation to require residents to carry health insurance is grappling with escalating Medicaid rolls, but a fix floated by Massachusetts ’ Republican governor is drawing pushback from employers. (Source: WSJ.com: Health)
Source: WSJ.com: Health - January 26, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news

U.S. Health Care by the Numbers
As Congress looks to shake up the U.S. health-insurance system, it ’s worth taking a look at what lawmakers are up against: an expensive health-care network that doesn’t deliver the best results. (Source: WSJ.com: Health)
Source: WSJ.com: Health - January 25, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news

Novartis Weighs Alcon Spinoff
Novartis said it was considering options for its ailing eye-care business Alcon, one year into a slower-than-expected turnaround for that business. (Source: WSJ.com: Health)
Source: WSJ.com: Health - January 25, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news

'Hamilton' Sued Over Show's Lack of Services for Blind Patrons
After trying to get the play ’s producers to add live audio narration, a man has filed suit against Hamilton’s producers and the owner of the theater, claiming the lack of such a service violates federal disability laws. (Source: WSJ.com: Health)
Source: WSJ.com: Health - January 25, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news

Federal Judge Blocks Aetna-Humana Merger on Antitrust Grounds
A federal judge Monday blocked the proposed merger of health insurers Aetna and Humana on antitrust grounds, a potentially fatal legal blow to the $34 billion deal. (Source: WSJ.com: Health)
Source: WSJ.com: Health - January 24, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news

After Trump's Health-Law Directive, a Dash to Decode It
Lawmakers, insurers and the health-care industry rushed over the weekend to decipher the full meaning and consequences of President Trump ’s executive order urging agency heads to do whatever they can to unwind some provisions of the Affordable Care Act. (Source: WSJ.com: Health)
Source: WSJ.com: Health - January 22, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news

GOP Governors Warn Lawmakers About Repeal of Affordable Care Act
John Kasich, Brian Sandoval and other governors have voiced concerns about the effects of abruptly scrapping the 2010 health law, as Republicans in Congress weigh their options. (Source: WSJ.com: Health)
Source: WSJ.com: Health - January 20, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news

Mallinckrodt Settles Antitrust Allegations on Unlawful Drug Monopoly
Irish drugmaker Mallinckrodt and a U.S. subsidiary will pay $100 million and agree to other conditions to settle government antitrust allegations they unlawfully prevented competition for Acthar, a drug that has seen enormous price spikes in recent years. (Source: WSJ.com: Health)
Source: WSJ.com: Health - January 19, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news

Mystery Fungus Sparks NIH Crisis, Imperiling Trials, Patients and Its Boss
Crisis response at the National Institutes of Health has prompted lab closures and has triggered delays in treatment. Its chief, noted geneticist Francis Collins, who serves at the pleasure of the president, is in the hot seat. (Source: WSJ.com: Health)
Source: WSJ.com: Health - January 19, 2017 Category: Pharmaceuticals Tags: FREE Source Type: news

Tom Price Is a Harbinger of Health Care Under Donald Trump
Tom Price, Donald Trump ’s nominee to be secretary of the Department of Health and Human Services, hopes to remedy a health-care system he believes is badly broken. Critics fear he will only make it worse. (Source: WSJ.com: Health)
Source: WSJ.com: Health - January 18, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news

Second Theranos Lab Failed U.S. Inspection
Theranos failed a second major U.S. regulatory inspection of its laboratory facilities, people familiar with the situation said, a setback the Silicon Valley blood-testing firm hasn ’t disclosed to investors or patients. (Source: WSJ.com: Health)
Source: WSJ.com: Health - January 18, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news

'Obamacare' Gets Higher Marks in New Poll
Americans are starting to warm up to the Affordable Care Act amid concerns about Republicans ’ efforts to dismantle it, a new Wall Street Journal/NBC News poll finds. (Source: WSJ.com: Health)
Source: WSJ.com: Health - January 18, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news